Surgical Science Sweden AB (publ) (SUS.ST)
SEK 108.6
(-6.54%)
SEK 108.6
(-6.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 191.28 Million SEK | 17.69% |
| 2022 | 162.53 Million SEK | 83.14% |
| 2021 | 88.75 Million SEK | 344.33% |
| 2020 | 19.97 Million SEK | 31.61% |
| 2019 | 15.17 Million SEK | 472.99% |
| 2018 | -4.06 Million SEK | -8.94% |
| 2017 | -3.73 Million SEK | -1767.5% |
| 2016 | -200 Thousand SEK | -111.11% |
| 2015 | 1.8 Million SEK | 161.09% |
| 2014 | -2.94 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 22.08 Million SEK | -59.05% |
| 2024 Q2 | 31.35 Million SEK | 51.36% |
| 2023 Q3 | 50.69 Million SEK | 6.64% |
| 2023 FY | 191.28 Million SEK | 17.69% |
| 2023 Q1 | 53.26 Million SEK | -12.99% |
| 2023 Q2 | 47.53 Million SEK | -10.76% |
| 2023 Q4 | 53.93 Million SEK | 6.39% |
| 2022 Q1 | 15.79 Million SEK | -64.5% |
| 2022 FY | 162.53 Million SEK | 83.14% |
| 2022 Q4 | 61.21 Million SEK | 0.74% |
| 2022 Q3 | 60.76 Million SEK | 7.42% |
| 2022 Q2 | 56.57 Million SEK | 258.23% |
| 2021 Q2 | 2.23 Million SEK | -0.58% |
| 2021 Q1 | 2.24 Million SEK | -82.26% |
| 2021 FY | 88.75 Million SEK | 344.33% |
| 2021 Q4 | 44.47 Million SEK | 487.49% |
| 2021 Q3 | 7.57 Million SEK | 239.51% |
| 2020 Q1 | -807 Thousand SEK | -106.5% |
| 2020 Q3 | 7.3 Million SEK | 771.12% |
| 2020 Q4 | 12.64 Million SEK | 73.19% |
| 2020 FY | 19.97 Million SEK | 31.61% |
| 2020 Q2 | 838 Thousand SEK | 203.84% |
| 2019 Q1 | -5.06 Million SEK | -256.86% |
| 2019 FY | 15.17 Million SEK | 472.99% |
| 2019 Q3 | 9.5 Million SEK | 666.89% |
| 2019 Q4 | 12.42 Million SEK | 30.72% |
| 2019 Q2 | -1.67 Million SEK | 66.93% |
| 2018 Q2 | -1.8 Million SEK | 60.0% |
| 2018 FY | -4.06 Million SEK | -8.94% |
| 2018 Q3 | -1 Million SEK | 44.44% |
| 2018 Q4 | 3.23 Million SEK | 423.1% |
| 2018 Q1 | -4.5 Million SEK | -275.44% |
| 2017 Q4 | 2.56 Million SEK | 175.44% |
| 2017 Q1 | -500 Thousand SEK | -106.94% |
| 2017 FY | -3.73 Million SEK | -1767.5% |
| 2017 Q2 | -2.4 Million SEK | -380.0% |
| 2017 Q3 | -3.4 Million SEK | -41.67% |
| 2016 Q2 | -2.1 Million SEK | -90.91% |
| 2016 Q1 | -1.1 Million SEK | 0.0% |
| 2016 Q3 | -4.2 Million SEK | -100.0% |
| 2016 FY | -200 Thousand SEK | -111.11% |
| 2016 Q4 | 7.2 Million SEK | 271.43% |
| 2015 FY | 1.8 Million SEK | 161.09% |
| 2014 FY | -2.94 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aino Health AB (publ) | -9.51 Million SEK | 2110.796% |
| Bonzun AB (publ) | -25.25 Million SEK | 857.423% |
| Kontigo Care AB (publ) | 52 Thousand SEK | -367759.615% |
| Medhelp Care Aktiebolag (publ) | -10.48 Million SEK | 1924.561% |
| RaySearch Laboratories AB (publ) | 114.88 Million SEK | -66.51% |